Scholarly Index
Carlo Gambacorti‐Passerini
Azienda Ospedaliera San Gerardo; 40,691 total citations; 604 total publications; best world rank #48
Azienda Ospedaliera San Gerardo
40,691Total citations
604Total publications
87H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Myeloid Leukemia Treatments | Lifetime | 56 | IT 5 | 99.65 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 127 | IT 9 | 99.59 |
| Eosinophilic Disorders and Syndromes | Lifetime | 48 | IT 7 | 99.40 |
| Acute Lymphoblastic Leukemia research | Lifetime | 300 | IT 21 | 98.82 |
| Lymphoma Diagnosis and Treatment | Lifetime | 716 | IT 49 | 98.31 |
| Lung Cancer Treatments and Mutations | Lifetime | 880 | IT 45 | 98.26 |
| Retinoids in leukemia and cellular processes | Lifetime | 488 | IT 31 | 96.17 |
| HER2/EGFR in Cancer Research | Lifetime | 946 | IT 61 | 96.26 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 850 | IT 108 | 94.46 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 176 | IT 19 | 96.79 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 357 | IT 22 | 96.29 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 461 | IT 31 | 93.18 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 329 | IT 53 | 87.64 |